Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET

Go back to Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
(NASDAQ: LTRN) Delayed: 3.88 --0 (-0%)
Previous Close $3.88    52 Week High
Open $3.88    52 Week Low
Day High $3.88    P/E N/A 
Day Low $3.88    EPS
Volume 114